Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hexue Tongbi Fang (和血通痹方) is a Traditional Chinese Medicine (TCM) formula developed by the First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine. It is composed of five herbal ingredients: Aconiti radix cocta (制川乌), Cassia twig (桂枝), Manchurian wild ginger (细辛), Armand clematis stem (威灵仙), and Angelica dahurica (白芷), each at a dosage of 10g. The formula is prepared as an external powder decoction, used for fumigation and soaking of hands and feet. It has demonstrated preventive and therapeutic effects on oxaliplatin-induced peripheral neuropathy (OIPN) in a randomized controlled study and animal experiments. Network pharmacology studies suggest its multi-target effects involve the upregulation and modulation of the PI3K/Akt signaling pathway, including PI3K, Akt1, Akt2, and Bcl-2, contributing to its neuroprotective and analgesic properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Hexue Tongbi Fang.